Key Financial Data Of Group

COSMOS Pharmaceutical Corporation - Filing #7730595

Concept As at
2017-11-30
2017-06-01 to
2017-11-30
2017-09-01 to
2017-11-30
2016-06-01 to
2017-05-31
As at
2017-05-31
2016-06-01 to
2016-11-30
As at
2016-11-30
2016-09-01 to
2016-11-30
Key financial data of group
Business results of group
Net sales
270,835,000,000 JPY
502,732,000,000 JPY
247,044,000,000 JPY
Ordinary profit (loss)
11,589,000,000 JPY
24,591,000,000 JPY
13,043,000,000 JPY
Profit (loss) attributable to owners of parent
7,781,000,000 JPY
18,215,000,000 JPY
8,683,000,000 JPY
Comprehensive income
7,790,000,000 JPY
18,260,000,000 JPY
8,734,000,000 JPY
Net assets
99,952,000,000 JPY
93,053,000,000 JPY
84,219,000,000 JPY
Total assets
234,345,000,000 JPY
225,691,000,000 JPY
209,343,000,000 JPY
Basic earnings (loss) per share
393.00
158.71
919.99
438.58
205.50
Diluted earnings per share
Equity-to-asset ratio
0.427 xbrli:pure
0.412 xbrli:pure
0.402 xbrli:pure
Net cash provided by (used in) operating activities
11,683,000,000 JPY
36,938,000,000 JPY
13,133,000,000 JPY
Net cash provided by (used in) investing activities
-14,173,000,000 JPY
-28,404,000,000 JPY
-13,568,000,000 JPY
Net cash provided by (used in) financing activities
-4,075,000,000 JPY
-8,088,000,000 JPY
-4,252,000,000 JPY
Cash and cash equivalents
21,162,000,000 JPY
27,728,000,000 JPY
22,594,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.